SEENEZ GH Trial: Stakeholder Interview Data on Growth Hormone Treatment Preferences

A qualitative dataset from the SEENEZ GH trial, containing interview data from 26 participants. The data was collected by researchers to analyze preferences for continuing or discontinuing growth hormone treatment in adolescents with transient idiopathic isolated growth hormone deficiency. The dataset was uploaded by figshare admin karger and last updated on April 22, 2026.

Use Cases

• Analyzing patient and parent preferences for treatment continuation based on themes of reassurance and uncertainty.
• Studying healthcare professional perspectives on treatment discontinuation based on cited factors like cost-effectiveness and ethical concerns.
• Identifying facilitators and barriers for clinical guideline revision based on interview responses about communication and resources.

Strengths

• Includes interview data from 26 participants across four stakeholder groups: patients, parents, healthcare professionals, and organizational employees.
• Dataset is openly available under a CC-BY-4.0 license, permitting broad reuse with attribution.

Limitations

• Row count is unknown, which may limit suitability assessment.
• Column-level documentation is absent; field semantics must be inferred after download.
• The dataset is small at 125.7 KB, indicating limited scope.

Provenance

Source

figshare admin karger

Collection Method

Data was gathered through 25 semi-structured interviews combining a structured impact analysis tool with open-ended questions.

Freshness

Last updated 2026-04-22 05:55:10; freshness should be verified.